News

23 May: Aficamten Advancing for Cardiomyopathy After SEQUOIA-HCM

LISBON, Portugal — A novel oral drug offers clinically meaningful improvements in exercise capacity in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) and reduces the burden of limiting symptoms, new data from the SEQUOIA-HCM trial reveal. Aficamten is an investigational next-generation selective cardiac myosin inhibitor that reduces left ventricular contractility…

Fat-enlarged axillary nodes on mammogram may indicate higher CVD risk

15 May: Fat-enlarged axillary nodes on mammogram may indicate higher CVD risk

Fat-enlarged axillary nodes on screening mammograms can predict the risk for cardiovascular disease (CVD), according to a study presented at the annual meeting of the American Roentgen Ray Society, held May 5–9 in Boston. Jessica Rubino, M.D., from the Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, and colleagues used electronic medical record data from

Researchers show genetic variant common among Black Americans contributes to large cardiovascular disease burden

12 May: Researchers show genetic variant common among Black Americans contributes to large cardiovascular disease burden

Editors’ notes This article has been reviewed according to Science X’s editorial process and policies. Editors have highlighted the following attributes while ensuring the content’s credibility: fact-checked peer-reviewed publication trusted source proofread by Brigham and Women’s Hospital Credit: AI-generated image Researchers at Brigham and Women’s Hospital and Duke University showed that a genetic variant, present in

Study finds COVID-19 vaccine can help people with heart failure live longer

11 May: Study finds COVID-19 vaccine can help people with heart failure live longer

Credit: Pixabay/CC0 Public Domain Heart failure patients who are vaccinated against COVID-19 have an 82% greater likelihood of living longer than those who are not vaccinated, according to research presented at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC), held 11–14 May in Lisbon, Portugal. Heart Failure is a life-threatening